Scotiabank Downgrades Blueprint Medicines (NASDAQ:BPMC) to Hold
Blueprint Medicines (NASDAQ:BPMC – Get Free Report) was downgraded by analysts at Scotiabank from a “strong-buy” rating to a “hold” rating in a report released...
Blueprint Medicines (NASDAQ:BPMC) Earns “Neutral” Rating from Wedbush
Blueprint Medicines (NASDAQ:BPMC – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Wedbush in a note issued to investors on Monday,...
Citigroup Forecasts Strong Price Appreciation for BRP (TSE:DOO) Stock
BRP (TSE:DOO – Free Report) had its target price raised by Citigroup from C$49.00 to C$60.00 in a report published on Tuesday morning,BayStreet.CA reports. Several...
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (NYSE:ETO) Short Interest Update
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (NYSE:ETO – Get Free Report) was the target of a significant growth in short interest during the month...
Nuveen California Quality Municipal Income Fund (NYSE:NAC) Sees Significant Growth in Short Interest
Nuveen California Quality Municipal Income Fund (NYSE:NAC – Get Free Report) saw a significant growth in short interest in May. As of May 15th, there...
Piper Sandler Increases Replimune Group (NASDAQ:REPL) Price Target to $22.00
Replimune Group (NASDAQ:REPL – Get Free Report) had its price target upped by investment analysts at Piper Sandler from $14.00 to $22.00 in a research...